MD1561Y - Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 - Google Patents
Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 Download PDFInfo
- Publication number
- MD1561Y MD1561Y MDS20210013A MDS20210013A MD1561Y MD 1561 Y MD1561 Y MD 1561Y MD S20210013 A MDS20210013 A MD S20210013A MD S20210013 A MDS20210013 A MD S20210013A MD 1561 Y MD1561 Y MD 1561Y
- Authority
- MD
- Moldova
- Prior art keywords
- days
- day
- once
- mixture
- ozone concentration
- Prior art date
Links
- 241001678559 COVID-19 virus Species 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- OGIIWTRTOXDWEH-UHFFFAOYSA-N [O].[O-][O+]=O Chemical compound [O].[O-][O+]=O OGIIWTRTOXDWEH-UHFFFAOYSA-N 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 229940004856 acetylcysteine 600 mg Drugs 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229940003827 azithromycin 500 mg Drugs 0.000 abstract 1
- 229940068661 cefuroxime 500 mg Drugs 0.000 abstract 1
- FBHSPRKOSMHSIF-GRMWVWQJSA-N deflazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O FBHSPRKOSMHSIF-GRMWVWQJSA-N 0.000 abstract 1
- 229960001145 deflazacort Drugs 0.000 abstract 1
- 230000037149 energy metabolism Effects 0.000 abstract 1
- 229960005153 enoxaparin sodium Drugs 0.000 abstract 1
- 230000002178 gastroprotective effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- CIJQTPFWFXOSEO-NDMITSJXSA-J tetrasodium;(2r,3r,4s)-2-[(2r,3s,4r,5r,6s)-5-acetamido-6-[(1r,2r,3r,4r)-4-[(2r,3s,4r,5r,6r)-5-acetamido-6-[(4r,5r,6r)-2-carboxylato-4,5-dihydroxy-6-[[(1r,3r,4r,5r)-3-hydroxy-4-(sulfonatoamino)-6,8-dioxabicyclo[3.2.1]octan-2-yl]oxy]oxan-3-yl]oxy-2-(hydroxy Chemical compound [Na+].[Na+].[Na+].[Na+].O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1O)NC(C)=O)O[C@@H]1C(C[C@H]([C@@H]([C@H]1O)O)O[C@@H]1[C@@H](CO)O[C@H](OC2C(O[C@@H](OC3[C@@H]([C@@H](NS([O-])(=O)=O)[C@@H]4OC[C@H]3O4)O)[C@H](O)[C@H]2O)C([O-])=O)[C@H](NC(C)=O)[C@H]1C)C([O-])=O)[C@@H]1OC(C([O-])=O)=C[C@H](O)[C@H]1O CIJQTPFWFXOSEO-NDMITSJXSA-J 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Invenţia se referă la medicină, în special la boli infecţioase şi pneumologie şi poate fi utilizată pentru tratamentul complex al infecţiei cu virusul SARS-CoV-2.Esenţa invenţiei constă în aceea că se administrează azitromicină 500 mg o dată pe zi, timp de 9 zile, cefuroxim 500 mg câte 1 tab. de 2 ori pe zi, timp de 14 zile, soluţie de enoxaparină sodică câte 0,4 ml de 2 ori pe zi, subcutanat, timp de 5 zile, deflazacort 45 mg, timp de 3 zile, apoi 37,5 mg, timp de 3 zile, apoi 30 mg, timp de 5 zile, apoi 22,5 mg, timp de 5 zile, apoi 15 mg, timp de 6 zile, aceticisteină 600 mg o dată pe zi, timp de 10 zile; terapie adjuvantă cu administrarea preparatelor gastroprotectoare, preparatelor cu acţiune asupra metabolismului energetic al organismului, aminoacizi, preparate pentru ameliorarea biocenozei intestinale şi sedative; concomitent se administrează intravenos 500 ml de soluţie ozonată de NaCl de 0,9% cu un amestec de oxigen-ozon, cu concetraţia ozonului de 5 µg/ml o dată pe zi, timp de 7 zile, apoi se prelungeşte cu soluţia menţionată cu concetraţia ozonului de 3 µg/ml o dată pe zi, timp de 5 zile, de asemenea se efectuează insuflaţii nazale şi rectale cu un amestec de oxigen-ozon, totodată insuflaţiile nazale se efectuează cu amestec cu concetraţia ozonului de 10 µg/ml, care se efectuează 5...7 min, zilnic, timp de 12 zile, iar insuflaţiile rectale se efectuează prin administrarea a 150...300 ml de amestec cu concetraţia ozonului de 10...25 µg/ml, zilnic, timp de 7 zile.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210013A MD1561Z (ro) | 2021-02-25 | 2021-02-25 | Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210013A MD1561Z (ro) | 2021-02-25 | 2021-02-25 | Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1561Y true MD1561Y (ro) | 2021-08-31 |
| MD1561Z MD1561Z (ro) | 2022-03-31 |
Family
ID=77635756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20210013A MD1561Z (ro) | 2021-02-25 | 2021-02-25 | Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1561Z (ro) |
-
2021
- 2021-02-25 MD MDS20210013A patent/MD1561Z/ro active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MD1561Z (ro) | 2022-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCullough et al. | Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections—A comprehensive review | |
| NZ595767A (en) | Composition for the treatment of prostate cancer | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| EP1369119B1 (en) | Il-12 expression controlling agents | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| HUP0301828A2 (hu) | Apomorfin alkalmazása nemi mżködészavar meghatározott apomorfin-plazmakoncentrációval történż kezelésre szolgáló készítmények elżállítására | |
| MD1561Y (ro) | Metodă de tratament complex al infecţiei cu virusul SARS-COV-2 | |
| MD3477F1 (ro) | Metoda de tratament al hepatitei virale cronice C | |
| CN1079255C (zh) | 一种治疗风湿痹症的药酒 | |
| RU2015111907A (ru) | Способ лечения хронического воспаления тканей пародонта и слизистой оболочки с элементами гиперкератоза у лиц молодого возраста | |
| US20100226863A1 (en) | Homeopathic medicament useful for immunomodulation | |
| RU2007118237A (ru) | Способ лечения аллергических заболеваний | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| RU2003113210A (ru) | Лечение раковых заболеваний | |
| RU2394565C1 (ru) | Способ лечения хронических фарингитов | |
| CN1488368A (zh) | 鼻炎清 | |
| US5116622A (en) | Methods for treating parkinson's disease | |
| RU95102611A (ru) | Способ лечения туберкулеза легких | |
| CN101548996A (zh) | 复方杨树花口服液及其制备方法 | |
| CN105582529A (zh) | 一种治疗脚气的药物组合物 | |
| RU2175557C1 (ru) | Способ предупреждения воспалительных заболеваний верхних дыхательных путей | |
| RU94037981A (ru) | Способ профилактики и лечения желудочно-кишечных болезней телят | |
| MD2327F1 (ro) | Metoda de tratament al afectiunilor parodontiului |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued |